Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1988 May;32(5):611–616. doi: 10.1128/aac.32.5.611

Therapeutic implications of bacteriologic findings in mixed aerobic-anaerobic infections.

S M Finegold 1, H M Wexler 1
PMCID: PMC172239  PMID: 3293522

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartlett J. G., Dezfulian M., Joiner K. Relative efficacy and critical interval of antimicrobial agents in experimental infections involving bacteroides fragilis. Arch Surg. 1983 Feb;118(2):181–184. doi: 10.1001/archsurg.1983.01390020037006. [DOI] [PubMed] [Google Scholar]
  2. Brook I. Encapsulated anaerobic bacteria in synergistic infections. Microbiol Rev. 1986 Dec;50(4):452–457. doi: 10.1128/mr.50.4.452-457.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cuchural G. J., Jr, Tally F. P., Jacobus N. V., Gorbach S. L., Aldridge K., Cleary T., Finegold S. M., Hill G., Iannini P., O'Keefe J. P. Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982. Antimicrob Agents Chemother. 1984 Aug;26(2):145–148. doi: 10.1128/aac.26.2.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cuchural G., Tally F. P. Factors affecting the choice of antimicrobial therapy for anaerobic infection. J Antimicrob Chemother. 1982 Aug;10 (Suppl A):11–22. doi: 10.1093/jac/10.suppl_a.11. [DOI] [PubMed] [Google Scholar]
  5. Finegold S. M., Rolfe R. D. Susceptibility testing of anaerobic bacteria. Diagn Microbiol Infect Dis. 1983 Mar;1(1):33–40. doi: 10.1016/0732-8893(83)90030-5. [DOI] [PubMed] [Google Scholar]
  6. Gorbach S. L., McGowan K. Comparative clinical trials in treatment of intra-abdominal sepsis. J Antimicrob Chemother. 1981 Dec;8 (Suppl 500):95–104. doi: 10.1093/jac/8.suppl_d.95. [DOI] [PubMed] [Google Scholar]
  7. Harding G., Vincelette J., Rachlis A., Fong I., Mandell L., Feld R., Bailey D. A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections. J Antimicrob Chemother. 1982 Nov;10 (Suppl 100):191–192. doi: 10.1093/jac/10.suppl_c.191. [DOI] [PubMed] [Google Scholar]
  8. Heimdahl A., von Konow L., Nord C. E. Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch Oral Biol. 1980;25(10):689–692. doi: 10.1016/0003-9969(80)90102-8. [DOI] [PubMed] [Google Scholar]
  9. Heseltine P. N., Berne T. V., Yellin A. E., Gill M. A., Appleman M. D. The efficacy of cefoxitin vs. clindamycin/gentamicin in surgically treated stab wounds of the bowel. J Trauma. 1986 Mar;26(3):241–245. doi: 10.1097/00005373-198603000-00005. [DOI] [PubMed] [Google Scholar]
  10. Jones R. N., Barry A. L., Fuchs P. C., Allen S. D. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure. Diagn Microbiol Infect Dis. 1987 Oct;8(2):87–94. doi: 10.1016/0732-8893(87)90154-4. [DOI] [PubMed] [Google Scholar]
  11. Kager L., Nord C. E. Imipenem/cilastatin in the treatment of intraabdominal infections: a review of worldwide experience. Rev Infect Dis. 1985 Jul-Aug;7 (Suppl 3):S518–S521. doi: 10.1093/clinids/7.supplement_3.s518. [DOI] [PubMed] [Google Scholar]
  12. Lamothe F., Auger F., Lacroix J. M. Effect of clavulanic acid on the activities of ten beta-lactam agents against members of the Bacteroides fragilis group. Antimicrob Agents Chemother. 1984 May;25(5):662–665. doi: 10.1128/aac.25.5.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Levison M. E., Mangura C. T., Lorber B., Abrutyn E., Pesanti E. L., Levy R. S., MacGregor R. R., Schwartz A. R. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med. 1983 Apr;98(4):466–471. doi: 10.7326/0003-4819-98-4-466. [DOI] [PubMed] [Google Scholar]
  14. Lou M. A., Chen D. F., Bansal M., Balasubramaniam S., Thadepalli H. Evaluation of ceftizoxime in acute peritonitis. J Antimicrob Chemother. 1982 Nov;10 (Suppl 100):183–189. doi: 10.1093/jac/10.suppl_c.183. [DOI] [PubMed] [Google Scholar]
  15. Nichols R. L., Smith J. W. Intragastric microbial colonization in common disease states of the stomach and duodenum. Ann Surg. 1975 Nov;182(5):557–561. doi: 10.1097/00000658-197511000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Polk B. F., Kasper D. L. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977 May;86(5):569–571. doi: 10.7326/0003-4819-86-5-569. [DOI] [PubMed] [Google Scholar]
  17. Sweet R. L., Robbie M. O., Ohm-Smith M., Hadley W. K. Comparative study of piperacillin versus cefoxitin in the treatment of obstetric and gynecologic infections. Am J Obstet Gynecol. 1983 Feb 1;145(3):342–349. doi: 10.1016/0002-9378(83)90722-6. [DOI] [PubMed] [Google Scholar]
  18. Ward A., Richards D. M. Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985 Nov;30(5):382–426. doi: 10.2165/00003495-198530050-00002. [DOI] [PubMed] [Google Scholar]
  19. Wexler H. M., Finegold S. M. Antimicrobial resistance in Bacteroides. J Antimicrob Chemother. 1987 Feb;19(2):143–146. doi: 10.1093/jac/19.2.143. [DOI] [PubMed] [Google Scholar]
  20. Wexler H. M., Finegold S. M. In vitro activity of selected antibiotics against anaerobes. Clin Ther. 1987;10 (Suppl A):12–18. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES